Art Taveras

Chief Tech/Sci/R&D Officer bei X4 PHARMACEUTICALS, INC.

Vermögen: 325 678 $ am 31.03.2024

60 Jahre

45 Beziehungen

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Art Taveras

Unternehmen	Position	Beginn	Ende
X4 PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	02.11.2020	-

Karriereverlauf von Art Taveras

Ehemalige bekannte Positionen von Art Taveras

Unternehmen	Position	Beginn	Ende
Transform Therapeutics	Chief Tech/Sci/R&D Officer	01.05.2015	01.11.2020
Transform Therapeutics	Founder	01.05.2015	01.11.2020
Comet Therapeutics, Inc. Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA.	Chief Tech/Sci/R&D Officer	01.08.2018	01.07.2020
Shanghai ChemPartner Co., Ltd. Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China.	Chief Tech/Sci/R&D Officer	01.10.2013	01.12.2014
	President	01.10.2013	01.12.2014
Biogen Idec, Inc. (North Carolina) Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.	Corporate Officer/Principal	01.01.2007	01.01.2013
Alantos Pharmaceuticals Holding, Inc. Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA.	Corporate Officer/Principal	01.05.2004	01.11.2007

Ausbildung von Art Taveras

Rensselaer Polytechnic Institute

Doctorate Degree

Statistik

International

Vereinigte Staaten	7
China	2

Operativ

Chief Tech/Sci/R&D Officer	4
Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Health Technology	5
Consumer Services	2
Commercial Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	1
X4 PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	5
Alantos Pharmaceuticals Holding, Inc. Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA.	Health Technology
Biogen Idec, Inc. (North Carolina) Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.	Health Technology
Shanghai ChemPartner Co., Ltd. Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China.	Commercial Services
Comet Therapeutics, Inc. Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA.	Health Technology
Transform Therapeutics

Sehen Sie sich die Unternehmensverbindungen an